Personal tools

Coexpression cluster:C4747: Difference between revisions

From FANTOM5_SSTAR

Jump to: navigation, search
(Created page with "{{Coexpression_clusters |full_id=C4747_Mast_retinoblastoma_testis_adrenal_epidermoid_prostate_chronic |id=C4747 }}")
 
No edit summary
Line 2: Line 2:
|full_id=C4747_Mast_retinoblastoma_testis_adrenal_epidermoid_prostate_chronic
|full_id=C4747_Mast_retinoblastoma_testis_adrenal_epidermoid_prostate_chronic
|id=C4747
|id=C4747
|ontology_enrichment_celltype=
|ontology_enrichment_disease=
|ontology_enrichment_uberon=UBERON:0002346!5.62e-17!90;UBERON:0003075!6.36e-17!86;UBERON:0007284!6.36e-17!86;UBERON:0001049!4.17e-16!57;UBERON:0005068!4.17e-16!57;UBERON:0006241!4.17e-16!57;UBERON:0007135!4.17e-16!57;UBERON:0005743!1.62e-15!86;UBERON:0001017!2.76e-15!82;UBERON:0000073!2.84e-15!94;UBERON:0001016!2.84e-15!94;UBERON:0002616!3.37e-14!59;UBERON:0000955!1.58e-13!69;UBERON:0006238!1.58e-13!69;UBERON:0002780!6.02e-13!41;UBERON:0001890!6.02e-13!41;UBERON:0006240!6.02e-13!41;UBERON:0007023!7.20e-13!115;UBERON:0003080!2.12e-12!42;UBERON:0003056!5.03e-12!61;UBERON:0000033!1.21e-11!123;UBERON:0002020!7.40e-11!34;UBERON:0003528!7.40e-11!34;UBERON:0000153!9.77e-11!129;UBERON:0007811!9.77e-11!129;UBERON:0001893!1.14e-10!34;UBERON:0002791!3.12e-10!33;UBERON:0001869!3.55e-10!32;UBERON:0000924!5.73e-09!173;UBERON:0006601!5.73e-09!173;UBERON:0004121!9.52e-09!169;UBERON:0000119!5.36e-08!312;UBERON:0000483!9.95e-08!309;UBERON:0000956!3.34e-07!25;UBERON:0000203!3.34e-07!25
}}
}}

Revision as of 14:52, 21 May 2012


Full id: C4747_Mast_retinoblastoma_testis_adrenal_epidermoid_prostate_chronic



Phase1 CAGE Peaks

Hg19::chr8:30770484..30770501,-p@chr8:30770484..30770501
-
Hg19::chr8:30770514..30770529,-p@chr8:30770514..30770529
-
Hg19::chr8:30770534..30770545,-p@chr8:30770534..30770545
-


Enriched pathways on this co-expression cluster<b>Summary:</b><br>Canonical pathway gene sets were compiled from Reactome, Wikipathways and KEGG. For the major signaling pathways, the transcriptionally-regulated genes (downstream targets) were obtained from Netpath. Combined, the canonical pathways and downstream targets totaled 489 human gene sets. The corresponding M. musculus gene sets were inferred by homology using the HomoloGene database. Enrichment for each of the canonical 489 pathways and gene sets included in the co-expression cluster was assessed by the hypergeometric probability. The resulting P values were also then adjusted by the Benjamini-Hochberg method for multiple comparisons.<br><b>Analyst: </b>Emmanuel Dimont<br><br>link to source dataset<br>data


No results for this coexpression

Enriched Gene Ontology terms on this co-expression cluster<b>Summary:</b> Results for GOStat analysis on co-expressed clusters. Each cluster with promoters mapping to at least two different genes was analysed with GOStat (PMID: 14962934) with default parameter. <br><b>Analyst:</b> Erik Arner<br><br>link to source dataset<br>data


No GOStat results

Enriched sample ontology terms on this co-expression cluster<b>Summary:</b>To summarize promoter activities (expression profile of a TSS region) across ~1000 samples, we performed enrichment analysis based on FANTOM5 Sample Ontology (FF ontology). The question here is “in which type of samples the promoter is more active”. To answer this question, we compared expressions (TPMs) in the samples associated with a sample ontology term and the rest of the samples by using the Mann-Whitney rank sum test. To summarize ontologies enriched in this co-expression cluster, we ran the same analysis on an averaged expression profile of all promoters that make up. <b>Analyst:</b> Hideya Kawaji <br><br>links to source dataset<br><br><br>uberon_data<br><br>


Uber Anatomy
Ontology termp-valuen
neurectoderm5.62e-1790
neural plate6.36e-1786
presumptive neural plate6.36e-1786
neural tube4.17e-1657
neural rod4.17e-1657
future spinal cord4.17e-1657
neural keel4.17e-1657
central nervous system2.76e-1582
regional part of nervous system2.84e-1594
nervous system2.84e-1594
regional part of brain3.37e-1459
brain1.58e-1369
future brain1.58e-1369
regional part of forebrain6.02e-1341
forebrain6.02e-1341
future forebrain6.02e-1341
adult organism7.20e-13115
anterior neural tube2.12e-1242
pre-chordal neural plate5.03e-1261
head1.21e-11123
gray matter7.40e-1134
brain grey matter7.40e-1134
anterior region of body9.77e-11129
craniocervical region9.77e-11129
telencephalon1.14e-1034
regional part of telencephalon3.12e-1033
cerebral hemisphere3.55e-1032
ectoderm5.73e-09173
presumptive ectoderm5.73e-09173
ectoderm-derived structure9.52e-09169
cell layer5.36e-08312
epithelium9.95e-08309
cerebral cortex3.34e-0725
pallium3.34e-0725


Overrepresented TFBS (DNA) motifs on this co-expression cluster<b>Summary:</b>The values shown are the p-values for overrepresentation of the motif in this coexpression cluster. So a small p-value means a strong overrepresentation. <b>Analyst:</b> Michiel de Hoon <br><br>link to source data <br> Novel motifs <br>data <br><br> Jaspar motifs <br>data


Novel motifs



JASPAR motifs

Motifs-log10(p-value)

{{{tfbs_overrepresentation_jaspar}}}



ENCODE TF ChIP-seq peak enrichment analysis<b>Summary:</b> For each TF and each co-expression cluster, the number of promoters with ENCODE TF ChIP signal was compared with the rest of promoters from the robust set using Fisher's exact test. Clusters with significant ChIP enrichment (q <= 0.05) after Benjamini-Hochberg correction were retained. <br><b>Analyst:</b> Erik Arner<br><br>link to source dataset<br><br>data


No analysis results for this cluster

Relative expression of the co-expression cluster<b>Summary:</b>Co-expression clusters are compared against FANTOM5 samples to obtain relative expression. <br><b>Analyst:</b>NA<br><br>link to data source<br> data


This analysis result is provided for C0 - C305 clusters.